SANARA MEDTECH INC. Income (Loss) from Equity Method Investments
SANARA MEDTECH INC. (SMTI) reported Income (Loss) from Equity Method Investments of -$433.65 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-11
- SANARA MEDTECH INC. income (loss) from equity method investments for the quarter ending 2026-06-30 was -$433.65K.
- SANARA MEDTECH INC. income (loss) from equity method investments for the quarter ending 2026-03-31 was -$462.51K.
- SANARA MEDTECH INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$324.73K.
- SANARA MEDTECH INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was -$288.64K.
- SANARA MEDTECH INC. income (loss) from equity method investments for fiscal 2025 was -$952.47K.
- SANARA MEDTECH INC. income (loss) from equity method investments for fiscal 2024 was -$90.01K.
- SANARA MEDTECH INC. income (loss) from equity method investments for fiscal 2022 was -$379.63K.
- SANARA MEDTECH INC. income (loss) from equity method investments for fiscal 2021 was -$616.93K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$433.65K 10-Q · filed 2026-08-11 | -$896.15K 10-Q · filed 2026-08-11 | -$1.22M derived: sum of 3 quarters · filed 2026-08-11 | -$1.51M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$462.51K 10-Q · filed 2026-05-12 | -$787.24K derived: sum of 2 quarters · filed 2026-05-12 | -$1.08M derived: sum of 3 quarters · filed 2026-05-12 | -$1.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$324.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$613.38K derived: sum of 2 quarters · filed 2026-03-24 | -$808.86K derived: sum of 3 quarters · filed 2026-08-11 | -$952.47K 10-K · filed 2026-03-24 |
| 2025-09-30 | -$288.64K 10-Q · filed 2025-11-12 | -$484.12K derived: sum of 2 quarters · filed 2026-08-11 | -$627.73K 10-Q · filed 2025-11-12 | -$686.29K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$195.48K 10-Q · filed 2026-08-11 | -$339.09K 10-Q · filed 2026-08-11 | -$397.65K derived: sum of 3 quarters · filed 2026-08-11 | -$429.10K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$143.61K 10-Q · filed 2026-05-12 | -$202.17K derived: sum of 2 quarters · filed 2026-05-12 | -$233.62K derived: sum of 3 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$58.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$90.01K derived: sum of 2 quarters · filed 2026-03-24 | -$90.01K 10-K · filed 2026-03-24 | |
| 2024-09-30 | -$31.45K 10-Q · filed 2025-11-12 | -$31.45K 10-Q · filed 2025-11-12 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | -$379.63K 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | -$379.63K 10-Q · filed 2023-11-13 | -$523.81K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$379.63K 10-Q · filed 2023-08-14 | -$523.81K derived: sum of 3 quarters · filed 2023-08-14 | -$717.66K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$379.63K 10-Q · filed 2023-05-15 | -$523.81K derived: sum of 2 quarters · filed 2023-05-15 | -$717.66K derived: sum of 3 quarters · filed 2023-05-15 | -$897.42K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$144.18K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$338.02K derived: sum of 2 quarters · filed 2023-03-20 | -$517.79K derived: sum of 3 quarters · filed 2023-03-20 | -$616.93K 10-K · filed 2023-03-20 |
| 2021-09-30 | -$193.84K 10-Q · filed 2022-11-14 | -$373.61K derived: sum of 2 quarters · filed 2022-11-14 | -$472.75K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$179.77K 10-Q · filed 2022-08-15 | -$278.90K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$99.14K 10-Q · filed 2022-05-16 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | |||
| 2018-12-31 | -$20.86K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$9.95K derived: sum of 2 quarters · filed 2019-04-01 | -$9.95K 10-K · filed 2019-04-01 | |
| 2018-09-30 | $10.91K 10-Q · filed 2018-11-14 | $10.91K 10-Q · filed 2018-11-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $0.00 10-K · filed 2019-04-01 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2011-09-30 | $11.65K 10-Q · filed 2012-11-14 | $11.65K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B |